Who is sponsoring NCT04596423?

NCT04596423 is sponsored by Assiut University.

What drugs are being tested in NCT04596423?

Interventions in NCT04596423: Fetal echocardiography.

What condition does NCT04596423 study?

NCT04596423 studies Fetal Echocardiography.

Is NCT04596423 still recruiting?

NCT04596423 is currently completed. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT04596423

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sief_Twist Sign a Novel View in Fetal Echocardiography

Completed Last updated 20 February 2024

What this trial tests

trial testing Fetal echocardiography in Fetal Echocardiography in 600 participants. Completed in 4 February 2024.

Timeline

1 January 2020

Primary endpoint
1 October 2023

4 February 2024

Quick facts

Lead sponsor	Assiut University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	600
Start date	1 January 2020
Primary completion	1 October 2023
Estimated completion	4 February 2024
Sites	1 location across Egypt

Drugs / interventions tested

Fetal echocardiography

Conditions studied

Fetal Echocardiography — all drugs for Fetal Echocardiography →

Sponsor

Assiut University

Who can join

Adults 18 to 35, female only, with Fetal Echocardiography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To describe Sief\_twist sign as a novel sign in fetal echocardiography as a new ,easy , time effective view in fetal heart examination .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Fetal echocardiography

Trials testing the same drug.

NCT05260931 — Fetal Cardiac Remodeling in Gestational Diabetic Pregnancies at the Moment of Diagnosis · unknown
NCT03146507 — Assessment of Cardiac Sparing in Fetal Hypoxia · NA · completed

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04596423 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04596423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing